Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0231807 (
exertional dyspnea
)
3,402
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In a previous study on pregnant rabbits (Am J Obstet Gynecol 1983; 147:437) we found that a prolonged infusion of the beta 2-adrenergic-receptor agonist terbutaline would first cause a release of fetal pulmonary surfactant, so that more was available in the airways. However, the airway fluid then contained less surfactant, indicating a depletion of stores. Since terbutaline is often used in high doses as a tocolytic agent, surfactant depletion could be a serious side effect. With further studies on rabbits, we wanted to test the hypothesis that with an accelerated surfactant synthesis, achieved with glucocorticoids, the increased release, evoked with the terbutaline, would never cause a depletion of the surfactant stores. Our results supported this hypothesis. Betamethasone, administered to the pregnant
doe
on the twenty-sixth and twenty-seventh days of gestation, 0.1 mg/kg, increased compliance of the fetal lungs, and more phospholipid
phosphorus
could be lavaged from the airways. These effects were further increased when, following steroid administration, the
doe
was infused with terbutaline. Depletion of the surfactant stores was never seen when betamethasone was given prior to the beta-adrenergic-receptor agonist.
...
PMID:Glucocorticoids and beta-adrenergic-receptor agonists: their combined effect on fetal rabbit lung surfactant. 383 27
Seven yearling Alpine does were in a series of balance trials to determine apparent utilization of fiber, protein, and minerals. The 34 kg does consumed 2.2% body weight of a hay-concentrate ration that was 18.8% crude protein, 40.9% neutral detergent fiber, 24.7% acid detergent fiber, 1.18% calcium, .67%
phosphorus
, .39% magnesium, .98% potassium, and .48% sodium. Digestion coefficients were 59.5, 68.5, 42.3, 70.6, and 29.3 for dry matter, crude protein, neutral detergent fiber, hemicellulose, and acid detergent fiber. Retention (g/day) was: 2.6, 1.3, 2.1, 1.8, and 1.1 for calcium,
phosphorus
, potassium, sodium, and magnesium. Nitrogen intake was related in a positive linear fashion to fecal nitrogen, urinary nitrogen, and absorbed nitrogen. Apparent absorption rates were 2.7, 1.4, 1.3, 5.1, and 3.2 g per
doe
per day for calcium,
phosphorus
, magnesium, potassium, and sodium. Mineral retentions as percent of grams apparently absorbed were 96.2, 88.2, 80.9, 37.7, and 56.0.
...
PMID:Protein, fiber, and mineral nutrition of growing dairy goats. 609 74
Biochemical products have been widely used for treatment of various types of wastewater. The treatment processes with the addition of biochemical products are quite attractive because of their simplicity, minimal use of equipment, they are environmentally friendly and are suitable for the removal of organic pollutants. The purpose of these products is to enhance the activities of beneficial microbes in order to improve treatment performance. This study was carried out to determine the potential of applying biochemical products in assisting and improving the performance of sewage treatment plants. In this study, four biochemical products, namely: Zeolite, Bio-C, Eco-B and Was-D, were applied to the sewage treatment plant. Analyses were carried out on several water quality parameters such as biochemical oxygen demand (BOD), chemical oxygen demand (COD), suspended solids (SS), oil & grease (O&G),
phosphorus
(P), ammoniacal nitrogen (AN) and sludge thickness (ST). From the results obtained, it can be seen that the overall performance of the treatment plant improved with most of the parameters studied were found to fulfill the
DOE
Standard B requirements. The performance of Bio-C was found to give better results than other products.
...
PMID:Application of biochemical products as a bioremediation technique for domestic sewage treatment plants. 1795 65
The association between hypocalcemia and heart failure is rare. There are few reported cases in the literature of this association, which is termed hypocalcemic cardiomyopathy. We report the case of a 61-year-old woman with no relevant medical history, admitted for progressively worsening
exertional dyspnea
, orthopnea and edema of the lower limbs for a previous month. Physical examination showed diffuse muscle spasms, with no signs of latent tetany.Further investigation revealed ionized calcium 0.54 mmol/l (normal 1.12-1.30),
phosphorus
9.8 mg/dl, parathyroid hormone <2.5 pg/ml and CK >3000 U/l, with normal thyroid function. The electrocardiogram showed long QT interval and a pattern of left ventricular overload, and myocardial biomarkers were negative. The echocardiogram revealed regional wall motion abnormalities, coronary angiography was normal and a cranial CT scan detected calcification of basal ganglia and white matter. She started diuretic and calcium replacement therapy which resulted in complete clinical recovery, with no need for heart failure therapy after normalization of serum calcium.
...
PMID:Hypocalcemic cardiomyopathy. 2358 87